Won-Soo Lee
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Won-Soo Lee has a total of 225 co-authors. Here are the top co-authors by number of shared publications:
Solam Lee
Department of Dermatology and Institute of Hair and Cosmetic Medicine, Yonsei University Wonju College of Medicine, Wonju, Republic of Korea
18 shared publicationsSung Jay Choe
Department of Dermatology and Institute of Hair and Cosmetic Medicine, Yonsei University Wonju College of Medicine, Wonju, Republic of Korea
8 shared publicationsBeom Jun Kim
Department of Dermatology and Institute of Hair and Cosmetic Medicine, Yonsei University Wonju College of Medicine, Wonju, Republic of Korea
7 shared publications- Solam Lee
Department of Dermatology, Yonsei University Wonju College of Medicine, Wonju, Republic of Korea
7 shared publications Jaewoong Choi
Department of Dermatology and Institute of Hair and Cosmetic Medicine, Yonsei University Wonju College of Medicine, Wonju, Korea
5 shared publicationsLong-Quan Pi
Department of Dermatology, Yanbian University Hospital, Yanji, Jilin, China
5 shared publications
Latest Publications
- Open Access
- 23 July 2025
- Published by Wiley in Journal of the European Academy of Dermatology and Venereology
- Vol. 40 (2) , 210-223
Statement from the frontal fibrosing alopecia international expert alliance: SOFFIA 2024
Background: As the incidence of frontal fibrosing alopecia (FFA) continues to rise, there is a need for an optimal treatment algorithm for FFA. Objectives: To produce an international consensus statement on the treatment modalities and prognostic indicators of FFA. Methods: Sixty‐nine hair experts from six continents were invited to participate in a three‐round Delphi process. The final stage was held as a virtual meeting facilitated via Zoom. The consensus threshold was set at ≥66%. Results: Of 365 questions, expert consensus was achieved in 204 (56%) questions following completion of the three rounds. Three additional questions were included at the final meeting. The category with the strongest consensus agreement was disease monitoring (9; 100%). Questions pertaining to physical therapies achieved the least category consensus (15; 40%), followed by systemic therapy (45; 43%). Limitations: The study lacked sufficient representation from Africa and South America. Conclusions: SOFFIA highlights areas of agreement and disagreement among experts. Robust research is warranted to provide evidence‐based treatment recommendations.
- 23 July 2025
- Published by Wiley in Journal of the European Academy of Dermatology and Venereology
- Vol. 40 (2) , 210-223
Open AccessStatement from the frontal fibrosing alopecia international expert alliance: SOFFIA 2024
Background: As the incidence of frontal fibrosing alopecia (FFA) continues to rise, there is a need for an optimal treatment algorithm for FFA. Objectives: To produce an international consensus statement on the treatment modalities and prognostic indicators of FFA. Methods: Sixty‐nine hair experts from six continents were invited to participate in a three‐round Delphi process. The final stage was held as a virtual meeting facilitated via Zoom. The consensus threshold was set at ≥66%. Results: Of 365 questions, expert consensus was achieved in 204 (56%) questions following completion of the three rounds. Three additional questions were included at the final meeting. The category with the strongest consensus agreement was disease monitoring (9; 100%). Questions pertaining to physical therapies achieved the least category consensus (15; 40%), followed by systemic therapy (45; 43%). Limitations: The study lacked sufficient representation from Africa and South America. Conclusions: SOFFIA highlights areas of agreement and disagreement among experts. Robust research is warranted to provide evidence‐based treatment recommendations.
- Open Access
- 1 January 2025
- Published by XMLink in Annals of Dermatology
- Vol. 37 (1) , 1-11
Protective Effects of Korean Red Ginseng Against Oxidative Stress-Induced Damage in Human Hair
Jung SW, et al. Ann Dermatol. 2024 Oct;36:e64. https://doi.org/10.5021/ad.24.047
- 1 January 2025
- Published by XMLink in Annals of Dermatology
- Vol. 37 (1) , 1-11
Open AccessProtective Effects of Korean Red Ginseng Against Oxidative Stress-Induced Damage in Human Hair
Jung SW, et al. Ann Dermatol. 2024 Oct;36:e64. https://doi.org/10.5021/ad.24.047
- 12 June 2024
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 144 (11) , 2590-2592.e4
Autoimmune Connective Tissue and Dermatologic Diseases in Children with Autism Spectrum Disorder
- 12 June 2024
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 144 (11) , 2590-2592.e4
Autoimmune Connective Tissue and Dermatologic Diseases in Children with Autism Spectrum Disorder
- Open Access
- 8 January 2024
- Published by Scientific Scholar in Indian Journal of Dermatology, Venereology and Leprology
- Vol. 90 (2) , 235-237
Comparison of self-estimated and clinician-measured SALT score in patients with alopecia areata: Patients with alopecia areata perceive themselves as more severe than dermatologists
- 8 January 2024
- Published by Scientific Scholar in Indian Journal of Dermatology, Venereology and Leprology
- Vol. 90 (2) , 235-237
Open AccessComparison of self-estimated and clinician-measured SALT score in patients with alopecia areata: Patients with alopecia areata perceive themselves as more severe than dermatologists
- Open Access
- 1 January 2024
- Published by XMLink in Annals of Dermatology
- Vol. 36 (3) , 188-190
Alopecia Areata and Season of Onset: A Retrospective Study of 492 Cases
Lee SH, et al. Ann Dermatol. 2024 Jun;36(3):188-190. https://doi.org/10.5021/ad.23.032
- 1 January 2024
- Published by XMLink in Annals of Dermatology
- Vol. 36 (3) , 188-190
Open AccessAlopecia Areata and Season of Onset: A Retrospective Study of 492 Cases
Lee SH, et al. Ann Dermatol. 2024 Jun;36(3):188-190. https://doi.org/10.5021/ad.23.032
- 11 July 2023
- Published by Oxford University Press (OUP) in Clinical and Experimental Dermatology
- Vol. 48 (11) , 1230-1237
Prevalence and incidence of comorbid diseases and mortality risk associated with lichen planopilaris: a Korean nationwide population-based study
Background: Various comorbid diseases have been reported in patients with lichen planopilaris (LPP); however, data regarding the risks of incident diseases and mortality are lacking. Objectives: To investigate the risks of incident diseases and mortality associated with LPP. Methods: This was a retrospective nationwide population-based study, using data from the National Health Insurance Service Database of Korea from 2002 to 2019. Patients aged ≥ 18 years with three or more documented medical visits for LPP were included. The adjusted hazard ratios (aHRs) for incident disease outcomes and mortality were compared with 1 : 20 age-, sex-, insurance type- and income-level-matched controls. Results: In total, 2026 patients with LPP and 40 520 controls were analysed. The risks of incident systemic lupus erythematosus [aHR 1.91, 95% confidence interval (CI) 1.21–3.03], psoriasis (aHR 3.42, 95% CI 2.83–4.14), rheumatoid arthritis (aHR 1.39, 95% CI 1.19–1.63), lichen planus (aHR, 10.07, 95% CI 7.17–14.15), atopic dermatitis (aHR 2.15, 95% CI 1.90–2.44), allergic rhinitis (aHR 1.29, 95% CI 1.13–1.49), thyroid diseases (hyperthyroidism: aHR 1.42, 95% CI 1.14–1.77, hypothyroidism aHR 1.19 95% CI 1.01–1.41, and thyroiditis: aHR, 1.35, 95% CI 1.08–1.69), nonmelanoma skin cancer (aHR 2.33, 95% CI 1.00–5.44) and vitamin D deficiency (aHR 1.23, 95% CI 1.03–1.47) were higher in patients with LPP. Patients with LPP had a higher mortality rate than controls (aHR 1.30, 95% CI 1.04–1.61), although the risk was not significant after adjusting for comorbidities (aHR 1.08, 95% CI 0.87–1.34). Conclusions: Patients with LPP had a higher risk of various diseases following LPP diagnosis. Close follow-up is needed to optimize comprehensive patient care.
- 11 July 2023
- Published by Oxford University Press (OUP) in Clinical and Experimental Dermatology
- Vol. 48 (11) , 1230-1237
Prevalence and incidence of comorbid diseases and mortality risk associated with lichen planopilaris: a Korean nationwide population-based study
Background: Various comorbid diseases have been reported in patients with lichen planopilaris (LPP); however, data regarding the risks of incident diseases and mortality are lacking. Objectives: To investigate the risks of incident diseases and mortality associated with LPP. Methods: This was a retrospective nationwide population-based study, using data from the National Health Insurance Service Database of Korea from 2002 to 2019. Patients aged ≥ 18 years with three or more documented medical visits for LPP were included. The adjusted hazard ratios (aHRs) for incident disease outcomes and mortality were compared with 1 : 20 age-, sex-, insurance type- and income-level-matched controls. Results: In total, 2026 patients with LPP and 40 520 controls were analysed. The risks of incident systemic lupus erythematosus [aHR 1.91, 95% confidence interval (CI) 1.21–3.03], psoriasis (aHR 3.42, 95% CI 2.83–4.14), rheumatoid arthritis (aHR 1.39, 95% CI 1.19–1.63), lichen planus (aHR, 10.07, 95% CI 7.17–14.15), atopic dermatitis (aHR 2.15, 95% CI 1.90–2.44), allergic rhinitis (aHR 1.29, 95% CI 1.13–1.49), thyroid diseases (hyperthyroidism: aHR 1.42, 95% CI 1.14–1.77, hypothyroidism aHR 1.19 95% CI 1.01–1.41, and thyroiditis: aHR, 1.35, 95% CI 1.08–1.69), nonmelanoma skin cancer (aHR 2.33, 95% CI 1.00–5.44) and vitamin D deficiency (aHR 1.23, 95% CI 1.03–1.47) were higher in patients with LPP. Patients with LPP had a higher mortality rate than controls (aHR 1.30, 95% CI 1.04–1.61), although the risk was not significant after adjusting for comorbidities (aHR 1.08, 95% CI 0.87–1.34). Conclusions: Patients with LPP had a higher risk of various diseases following LPP diagnosis. Close follow-up is needed to optimize comprehensive patient care.
- 21 March 2023
- Published by Wiley in Pediatric Allergy and Immunology
- Vol. 34 (3) , e13931
Pre‐pregnancy maternal adenotonsillectomy increases alopecia areata and atopic dermatitis risk in children
- 21 March 2023
- Published by Wiley in Pediatric Allergy and Immunology
- Vol. 34 (3) , e13931
Pre‐pregnancy maternal adenotonsillectomy increases alopecia areata and atopic dermatitis risk in children
- Open Access
- 24 February 2023
- Published by Scientific Scholar in Indian Journal of Dermatology, Venereology and Leprology
- Vol. 89 (4) , 595-599
Prognosis in patients with alopecia areata with poliosis: A retrospective cohort study of 479 cases
- 24 February 2023
- Published by Scientific Scholar in Indian Journal of Dermatology, Venereology and Leprology
- Vol. 89 (4) , 595-599
Open AccessPrognosis in patients with alopecia areata with poliosis: A retrospective cohort study of 479 cases
- 21 February 2023
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 89 (1) , 149-151
Increased risk of alopecia areata in patients with autism spectrum disorders: A Korean nationwide population-based study
- 21 February 2023
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 89 (1) , 149-151
Increased risk of alopecia areata in patients with autism spectrum disorders: A Korean nationwide population-based study
- Open Access
- 1 January 2023
- Published by XMLink in Annals of Dermatology
- Vol. 35 (6) , 464-467
Hair Regrowth Outcomes of Superficial Cryotherapy in Patients with Alopecia Areata: A Systematic Review
Lim SH, et al. Ann Dermatol. 2023 Dec;35(6):464-467. https://doi.org/10.5021/ad.22.095
- 1 January 2023
- Published by XMLink in Annals of Dermatology
- Vol. 35 (6) , 464-467
Open AccessHair Regrowth Outcomes of Superficial Cryotherapy in Patients with Alopecia Areata: A Systematic Review
Lim SH, et al. Ann Dermatol. 2023 Dec;35(6):464-467. https://doi.org/10.5021/ad.22.095